Subareolar injection of 99m-Tc sulfur colloid for sentinel nodes identification in multifocal invasive breast cancer;Injection sous-areolaire de sulfocolloides techneties pour l'identification des ganglions sentinelles dans les cancers du sein invasifs a foyers multiples

Bulletin du Cancer

Volumn 86, Issue 11, 1999, Pages 939-945

  Mertz, Luc ^a   Mathelin, Carole ^a   Marin, Cristi ^a   Gairard, Béatrice ^a   Chenard, Marie Pierre ^a   Brettes, Jean Philippe ^a   Bellocq, Jean Pierre ^a   Constantinesco, André ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Breast cancer; Lymphoscintigraphy; Multicentric; Multifocal; Sentinel node

Indexed keywords

CYTOKERATIN; TECHNETIUM SULFUR COLLOID TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST AREOLA; BREAST CANCER; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG ADMINISTRATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; ADENOCARCINOMA; BREAST TUMOR; FEMALE; INJECTION; LUNG CARCINOMA; LYMPH NODE; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIPLE CANCER; NIPPLE; PAGET NIPPLE DISEASE; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; INJECTIONS; LYMPH NODES; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NIPPLES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0033227066     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Veronesi U, Luini A, Galimberti V. Extent of metastatic axillary involvement in 1 446 cases of breast cancer. Eur J Oncol 1990; 16: 127-33.
2. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645-53.
3. Alazraki N, Eshima D, Eshima LA, Herda S, Murray D, Vansant J, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Sem Nucl Med 1997; 27: 55-67.
4. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-66.
5. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 759-67.
6. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-8.
7. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SL, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-9.
8. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanomas. Arch Surg 1992; 127: 392-9.
9. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue to identify sentinel lymph node in breast cancer. Lancet 1997; 349: 1668-9.
10. Albertini JJ, Lyman GH, Cox C, Yeatman Y, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-22.
11. Krag D, Weaver D, Alex J, Fairbank J. Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-9.
12. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349: 1864-7.
13. McIntosh SA, Purushotham AD. Lymphatic mapping and sentinel node biopsy in breast cancer. Br J Surg 1998; 85: 1347-56.
14. Miltenburg DM, Miller C, Karamlous TB, Brunicardi FC. Meta-analysis of sentinel lymph node in breast cancer. Association for Academic Surgery, 1998, Nov. 20, Seattle.
15. McDivitt RW. Breast cancer multicentricity. In: McDivitt RW, Oberman HA, Ozello L, et al., eds. The Breast. Baltimore, Williams and Wilkins 1984: 139-48.
16. Holland R, Solke H, Veling J, Mravunac M, Hendriks J. Histologic multifocality of Tis, T1-2 breast carcinomas. Cancer 1985; 56: 979-90.
17. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349: 1864-71.
18. Krag D, Weawer D, Ashikaga T, Moffat F, Klimberg V, Shriver C, et al. The sentinel node in breast: a multicenter validation study. N Eng J Med 1998; 339: 941-7.
19. Barnwell JM, Arredondo M, Kollmorgen D, Gibbs J, Lamonica D, Carson W, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998; 5: 126-30.
20. Klimberg S, Rubio I, Henry R, Cowan C, Colvert M, Korourian S. Subareolar versus peritumoral injection for location of the sentinel node. Ann Surg 1999; 229: 860-5.
21. Mertz L, Mathelin C, Chalabraysse L, Gairard B, Brunot B, Bellocq JP, et al. Injection sous-aréolaire de sulfocolloïdes technétiés pour la détection des ganglions sentinelles dans le cancer du sein. Med Nucl 1998; 22: 297-303.
22. Mathelin C, Mertz L, Gairard B, Marin C, Bellocq JP, Brettes JP, et al. Subarcolar versus peritumoral injection of 99mTc sulfur colloid for sentinel node(s) detection in multifocal breast cancer. Eur J Nucl Med 1999; 26: S66.
23. Grant RN, Tabah EJ, Adair FE. The surgical significance of the subareolar plexus in cancer of the breast. Surgery 1959; 33: 71-9.
24. Sappey P. Traité d'anatomie descriptive. Paris, 1888.
25. Beitsch P, Clifford E. Improved lymphatic mapping technique for breast cancer. Eur J Nucl Med 1999; 26: S87.
26. Borgstein P. The sentinel concept. Wageningen, Ponsen & Looijien bv, 1999: 69-89.
27. Offodile R, Hoh C, Barsky SH, Nelson SD, Elashoff R, Eilber FR, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 1998; 82: 1704-12.
28. Borgstein PJ, Pijpers R, Comans E, Van Diest P, Boom R, Meijer S. Sentinel lymph node in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-83.
29. Bergqvist L, Strand SE, Person BRR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Sem Nucl Med 1983; 13: 9-19.
30. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-83.
31. Roumen RMH, Valkenburg JGM, Geusken LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23: 495-502.
32. O'Hea BJ, Hill ADK, El-shirbiny AM, Yeh SDJ, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-30.
33. Berman C, Williamson M, Guiliano R, Crawford S, Costello D, Shivers S, Reintgen D. Comparison of 2 cc versus 6 cc of radiopharmaceutical diluent in injections for breast lymphatic mapping. Eur J Nucl Med 1999; 26: S66.
34. Van der Ent FWC, Kengen RAM, Van der Pol HAG, Hoofwijk AGM. Sentinel node biopsy in breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with blue dye tracer. Eur J Nucl Med 1999; 26: S66.
35. Pijpers R, Collet GJ, Meijer S, Hoekstra OS. The impact of sentinel node biopsy in melanoma. Eur J Nucl Med 1995; 22: 1238-41.
36. Gill PG, Hall VE, Kirkwood I, Chatterton BE, Coventry B, Vernon-Roberts E. Lymphoscintigraphy for locating the sentinel lymph node in patients with breast cancer. Breast 1997; 6: 225.
37. Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981; 47: 170-5.
38. Veronesi U, Cascinelli N, Greco M, Bufalino R, Morabito A, Galluzzo D, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985; 202: 702-7.
39. Veronesi U, Cascinelli N, Bufalino R, Morabito A, Greco M, Galluzzo D, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 1983; 198: 681-4.
40. Lacour J, Bucalossi P, Cacers E, Jacobelli G, Koszarowski T, Le M, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Cancer 1976; 37: 206-14.
41. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1997; 36: 1775-80.
42. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Boom RPA, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m colloidal albumin in breast cancer. J Nucl Med 1997; 38: 366-8.
43. Mazzeo F, Accurso A, Petrella G, Capuano S, Maurelli L, Centena L, et al. Preoperative axillary lymphoscintigraphy in breast cancer: experience with subareolar injection of 99m-Tc nanocolloidal albumin. Nucl Med Commun 1986; 7: 5-16.
44. Cox C, Pendas S, Cox J, Joseph E, Shons A, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645-53.
45. Bass S, Cox C, McCann C, Dupont E, Berman C, Reintgen D. The effect of post-injection massage on the sensitivity of lymphatic mapping in breast cancer. Eur J Nuc Med 1999; 26: S66.